https://psychiatry.dev/wp-content/uploads/speaker/post-10592.mp3?cb=1666996313.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Reduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 StudyFull EntryReduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study –